Dr. Michael Eckrich
Claim this profileMethodist Children's Hospital
Studies Lymphoblastic Leukemia-Lymphoma
Studies Acute Lymphoblastic Leukemia
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Michael Eckrich
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Michael Eckrich has experience with
- Tisagenlecleucel
Breakdown of trials Michael Eckrich has run
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Eckrich specialize in?
Michael Eckrich focuses on Lymphoblastic Leukemia-Lymphoma and Acute Lymphoblastic Leukemia. In particular, much of their work with Lymphoblastic Leukemia-Lymphoma has involved CD19 positive patients, or patients who are undergoing treatment.
Is Michael Eckrich currently recruiting for clinical trials?
No, Michael Eckrich is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Michael Eckrich has studied deeply?
Yes, Michael Eckrich has studied treatments such as Tisagenlecleucel.
What is the best way to schedule an appointment with Michael Eckrich?
Apply for one of the trials that Michael Eckrich is conducting.
What is the office address of Michael Eckrich?
The office of Michael Eckrich is located at: Methodist Children's Hospital, San Antonio, Texas 78229 United States. This is the address for their practice at the Methodist Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.